Adam Armstrong

1.0k total citations · 1 hit paper
9 papers, 761 citations indexed

About

Adam Armstrong is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Adam Armstrong has authored 9 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 3 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Adam Armstrong's work include Pancreatic function and diabetes (3 papers), Pluripotent Stem Cells Research (2 papers) and CRISPR and Genetic Engineering (2 papers). Adam Armstrong is often cited by papers focused on Pancreatic function and diabetes (3 papers), Pluripotent Stem Cells Research (2 papers) and CRISPR and Genetic Engineering (2 papers). Adam Armstrong collaborates with scholars based in United States and Japan. Adam Armstrong's co-authors include Yogish C. Kudva, Michael Deeds, Jill Anderson, Dennis A. Gastineau, Henry J. Hiddinga, Arshad Jahangir, Norman L. Eberhardt, Seiga Ohmine, Tayaramma Thatava and Allan B. Dietz and has published in prestigious journals such as Blood, Journal of the American Society of Nephrology and Stem Cell Research & Therapy.

In The Last Decade

Adam Armstrong

9 papers receiving 755 citations

Hit Papers

Single dose streptozotocin-induced diabetes: consideratio... 2011 2026 2016 2021 2011 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Armstrong United States 5 330 260 194 102 89 9 761
Huanran Tan China 17 354 1.1× 162 0.6× 101 0.5× 101 1.0× 35 0.4× 32 820
Won Gu Jang South Korea 9 524 1.6× 181 0.7× 173 0.9× 135 1.3× 44 0.5× 12 810
Manuel Oliveira Portugal 18 214 0.6× 277 1.1× 136 0.7× 81 0.8× 74 0.8× 46 907
Octavian Savu Romania 10 266 0.8× 72 0.3× 171 0.9× 124 1.2× 54 0.6× 23 714
Xian Jin China 14 569 1.7× 148 0.6× 95 0.5× 109 1.1× 30 0.3× 31 1.1k
Peijian He United States 19 667 2.0× 208 0.8× 88 0.5× 111 1.1× 57 0.6× 36 925
Michael Deeds United States 6 245 0.7× 218 0.8× 223 1.1× 107 1.0× 109 1.2× 14 668
Bethany J. Holycross United States 17 257 0.8× 96 0.4× 176 0.9× 234 2.3× 84 0.9× 30 909
Prem Prakash India 19 339 1.0× 151 0.6× 79 0.4× 102 1.0× 24 0.3× 84 1.0k
Roberta Sanguineti Italy 14 410 1.2× 116 0.4× 168 0.9× 222 2.2× 60 0.7× 23 843

Countries citing papers authored by Adam Armstrong

Since Specialization
Citations

This map shows the geographic impact of Adam Armstrong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Armstrong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Armstrong more than expected).

Fields of papers citing papers by Adam Armstrong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Armstrong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Armstrong. The network helps show where Adam Armstrong may publish in the future.

Co-authorship network of co-authors of Adam Armstrong

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Armstrong. A scholar is included among the top collaborators of Adam Armstrong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Armstrong. Adam Armstrong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Dietz, Allan B., André J. van Wijnen, Greg W. Butler, et al.. (2017). A consistent, and predictable drug: The first 100 patients treated with autologous adipose derived mesenchymal stromal cells (MSCs) at the Mayo Clinic. Cytotherapy. 19(5). S155–S155. 1 indexed citations
2.
Saad, Ahmed, Allan B. Dietz, Sandra M. Herrmann, et al.. (2017). Autologous Mesenchymal Stem Cells Increase Cortical Perfusion in Renovascular Disease. Journal of the American Society of Nephrology. 28(9). 2777–2785. 122 indexed citations
3.
Lin, Yi, Thomas D. Atwell, Adam J. Weisbrod, et al.. (2015). Dendritic cell vaccine treatment for indolent B-cell non-Hodgkin lymphoma: clinical trial in progress. Cytotherapy. 17(6). S17–S17. 2 indexed citations
4.
Atwell, Thomas D., Adam J. Weisbrod, Mary Maas, et al.. (2014). Dendritic Cell Vaccine Treatment for B-Cell Non-Hodgkin Lymphoma: Clinical Trial in Progress. Blood. 124(21). 4474–4474. 3 indexed citations
5.
Kudva, Yogish C., Seiga Ohmine, Lucas Greder, et al.. (2012). Transgene-Free Disease-Specific Induced Pluripotent Stem Cells from Patients with Type 1 and Type 2 Diabetes. Stem Cells Translational Medicine. 1(6). 451–461. 57 indexed citations
6.
Ohmine, Seiga, Karen A. Squillace, Michael Deeds, et al.. (2012). Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency. Aging. 4(1). 60–73. 70 indexed citations
7.
Thatava, Tayaramma, Adam Armstrong, Ramakrishna Edukulla, et al.. (2011). Successful disease-specific induced pluripotent stem cell generation from patients with kidney transplantation. Stem Cell Research & Therapy. 2(6). 48–48. 47 indexed citations
8.
Deeds, Michael, Jill Anderson, Adam Armstrong, et al.. (2011). Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models. Laboratory Animals. 45(3). 131–140. 455 indexed citations breakdown →
9.
Anderson, Jill, Michael Deeds, Adam Armstrong, D A Gastineau, & Yogish C. Kudva. (2007). Utilization of a test gradient enhances islet recovery from deceased donor pancreases. Cytotherapy. 9(7). 630–636. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026